Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	468	789	797	611	1,109	118
Market Cap Growth	-8.03%	-0.94%	30.33%	-44.89%	836.40%	28.22%
Enterprise Value	516	833	816	634	1,119	136
PE Ratio	-	-12.61	-5.82	3.41	-2.06	-5.03
PS Ratio	351.21	408.63	473.52	608.42	859.37	49.16
PB Ratio	-11.57	-16.81	-6.22	-4.93	-3.06	-2.72
P/FCF Ratio	-10.81	-13.83	-14.31	-13.80	-28.67	-3.68
P/OCF Ratio	-11.27	-14.72	-15.10	-15.97	-34.57	-3.72
EV/Sales Ratio	386.09	431.11	484.98	631.08	867.02	56.49
EV/EBITDA Ratio	-11.69	-15.49	-12.43	-12.02	-12.99	-4.96
EV/EBIT Ratio	-11.32	-15.01	-12.16	-11.89	-12.92	-5.01
EV/FCF Ratio	-11.63	-14.59	-14.66	-14.31	-28.92	-4.23
Debt / Equity Ratio	-0.84	-0.88	-0.20	-0.31	-0.05	-0.41
Debt / EBITDA Ratio	-0.86	-0.85	-0.40	-0.72	-0.23	-0.66
Debt / FCF Ratio	-0.86	-0.80	-0.47	-0.86	-0.51	-0.56
Quick Ratio	0.04	0.05	0.06	0.11	0.03	0.01
Current Ratio	0.08	0.09	0.07	0.13	0.04	0.08
Asset Turnover	0.05	0.07	0.05	0.03	0.04	0.26
Interest Coverage	-10.37	-10.04	-11.07	-10.52	-10.14	-9.23
Return on Equity (ROE)	132.56%	133.26%	106.83%	-144.47%	148.33%	54.11%
Return on Assets (ROA)	-247.08%	-224.02%	-436.89%	446.03%	-1636.42%	-258.21%
Return on Capital (ROIC)	1350.51%	3920.06%	65.96%	59.75%	25.24%	107.55%
Earnings Yield	-15.08%	-7.93%	-17.17%	29.29%	-48.53%	-19.90%
FCF Yield	-12.18%	-7.23%	-6.99%	-7.25%	-3.49%	-27.19%
Buyback Yield / Dilution	-10.54%	-10.17%	-0.79%	-38.99%	-28.53%	-28.22%
Total Shareholder Return	-10.54%	-10.17%	-0.79%	-38.99%	-28.53%	-28.22%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.